NCT07183020View on ClinicalTrials.gov

Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

Enrolling by invitationOBSERVATIONAL
Enrollment

1,142

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Multiple SclerosisClinically Isolated Syndrome (CIS)
Interventions
DIAGNOSTIC_TEST

Oligoclonal bands and kappa free light chains (KFLC)

Comparison of oligoclonal bands and kappa free light chains (KFLC) in patients with multiple sclerosis (MS) / clinically isolated syndrome (CIS)

Trial Locations (1)

30625

Medizinische Hochschule Hannover / Hannover Medical School, Hanover

All Listed Sponsors
lead

Skripuletz, Thomas Prof. Dr.

OTHER